These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21816551)

  • 1. Methods for detection and confirmation of Hematide™/peginesatide in anti-doping samples.
    Leuenberger N; Saugy J; Mortensen RB; Schatz PJ; Giraud S; Saugy M
    Forensic Sci Int; 2011 Dec; 213(1-3):15-9. PubMed ID: 21816551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass spectrometric detection of peginesatide in human urine in doping control analysis.
    Möller I; Thomas A; Delahaut P; Geyer H; Schänzer W; Thevis M
    J Pharm Biomed Anal; 2012 Nov; 70():512-7. PubMed ID: 22884786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, characterisation, and mass spectrometric detection of a pegylated EPO-mimetic peptide for sports drug testing purposes.
    Möller I; Thomas A; Geyer H; Schänzer W; Thevis M
    Rapid Commun Mass Spectrom; 2011 Aug; 25(15):2115-23. PubMed ID: 21710591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of erythropoiesis-stimulating agents in human anti-doping control: past, present and future.
    Leuenberger N; Reichel C; Lasne F
    Bioanalysis; 2012 Jul; 4(13):1565-75. PubMed ID: 22831473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to confirm C.E.R.A. doping in athletes' blood?
    Leuenberger N; Lamon S; Robinson N; Giraud S; Saugy M
    Forensic Sci Int; 2011 Dec; 213(1-3):101-3. PubMed ID: 21889277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of peptidic erythropoiesis-stimulating agents in sport.
    Reichel C
    Br J Sports Med; 2014 May; 48(10):842-7. PubMed ID: 24677025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent developments in doping testing for erythropoietin.
    Reichel C
    Anal Bioanal Chem; 2011 Aug; 401(2):463-81. PubMed ID: 21637931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fc-fragment removal allows the EPO-Fc fusion protein to be detected in blood samples by IEF-PAGE.
    Postnikov P; Krotov G; Mesonzhnik N; Efimova Y; Rodchenkov G
    Drug Test Anal; 2015; 7(11-12):999-1008. PubMed ID: 26695487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Watch out for a revival of peginesatide in sports.
    Jelkmann W
    Drug Test Anal; 2017 Feb; 9(2):157-160. PubMed ID: 27279382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrimination of recombinant and endogenous urinary erythropoietin by calculating relative mobility values from SDS gels.
    Kohler M; Ayotte C; Desharnais P; Flenker U; Lüdke S; Thevis M; Völker-Schänzer E; Schänzer W
    Int J Sports Med; 2008 Jan; 29(1):1-6. PubMed ID: 18050057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abuse of medicines for performance enhancement in sport: why is this a problem for the pharmaceutical industry?
    Elliott S; Leishman B
    Bioanalysis; 2012 Jul; 4(13):1681-90. PubMed ID: 22831483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analytical challenges in the detection of peptide hormones for anti-doping purposes.
    Barroso O; Handelsman DJ; Strasburger C; Thevis M
    Bioanalysis; 2012 Jul; 4(13):1577-90. PubMed ID: 22831474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of peginesatide in equine serum using liquid chromatography-tandem mass spectrometry for doping control purposes.
    Möller I; Thomas A; Wingender A; Machnik M; Schänzer W; Thevis M
    Eur J Mass Spectrom (Chichester); 2012; 18(4):407-12. PubMed ID: 22971699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of erythropoiesis stimulating agents in urine samples using a capillary Western system.
    Desharnais P; Naud JF; Ayotte C
    Drug Test Anal; 2018 Nov; 10(11-12):1698-1707. PubMed ID: 30365250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple method to immunopurify erthyropoiesis stimulating agents from urine, aiming to optimize erythropoietin screening by SAR-PAGE.
    Heiland CE; Masquelier M; Bhuiyan H; Ericsson M
    Drug Test Anal; 2019 Nov; 11(11-12):1666-1674. PubMed ID: 31692286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of EPO-Fc fusion protein in human blood: screening and confirmation protocols for sports drug testing.
    Reichel C; Thevis M
    Drug Test Anal; 2012 Nov; 4(11):818-29. PubMed ID: 22764129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doping control analysis of recombinant human erythropoietin, darbepoetin alfa and methoxy polyethylene glycol-epoetin beta in equine plasma by nano-liquid chromatography-tandem mass spectrometry.
    Yu NH; Ho EN; Wan TS; Wong AS
    Anal Bioanal Chem; 2010 Apr; 396(7):2513-21. PubMed ID: 20148243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A high-throughput test to detect C.E.R.A. doping in blood.
    Lamon S; Giraud S; Egli L; Smolander J; Jarsch M; Stubenrauch KG; Hellwig A; Saugy M; Robinson N
    J Pharm Biomed Anal; 2009 Dec; 50(5):954-8. PubMed ID: 19625154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oxygen blood transport and doping].
    Audran M; Connes P; Varlet-Marie E
    Bull Acad Natl Med; 2003; 187(9):1669-79; discussion 1680-3. PubMed ID: 15369237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of the health industry in the fight against doping in sport.
    Rabin O
    Forensic Sci Int; 2011 Dec; 213(1-3):10-4. PubMed ID: 21741188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.